![]() Kringle Pharma Kringle Pharma is a clinical-stage biopharmaceutical company that focuses on the research and development of regenerative medicines. | ![]() Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | ![]() PharmaEssentia PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases. | |
Founding Date | Founding Date 2001 | Founding Date 1991 | Founding Date 2003 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Ibaraki, JP HQ | Locations Sunnyvale, US HQ | Locations Taipei, TW HQ Shinjuku City, JP Burlington, US |
Employees | Employees 13 | Employees 6551% decrease | Employees 4897% increase |
Financial | |||
Revenue (est.) | Revenue (est.) ¥72.2m (FY, 2025) | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) NT$15.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $40.4m (FY, 2014) | Cost of goods NT$1.3b (FY, 2025) |
Gross profit | Gross profit ¥72.2m (FY, 2025) | Gross profit $689.3m (FY, 2014) | Gross profit NT$14.4b (FY, 2025) |
Net income | Net income (¥916.3m) (FY, 2025) | Net income $86.1m (FY, 2014) | Net income NT$5b (FY, 2025) |

Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company
PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases.
View company